Cytosorbents Corp
CTSO· Nasdaq
Cytosorbents Corp
- Last sale
- Oct 2, 2026 · +4.88%
- Market cap
- $249.80M
- 62.84M shares
- Filings
- 977
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $37,063,000 | reported | |
| FY 2024 | 2024-12-31 | $35,595,000 | reported | |
| FY 2023 | 2023-12-31 | $31,084,953 revised | reported | |
| FY 2022 | 2022-12-31 | $34,688,809 | reported | |
| FY 2021 | 2021-12-31 | $43,165,527 | reported | |
| FY 2020 | 2020-12-31 | $41,004,601 | reported | |
| FY 2019 | 2019-12-31 | $24,949,473 | reported | |
| FY 2018 | 2018-12-31 | $22,503,908 | reported | |
| FY 2017 | 2017-12-31 | $15,150,754 | reported | |
| FY 2016 | 2016-12-31 | $9,527,843 | reported | |
| FY 2015 | 2015-12-31 | $4,791,616 | reported | |
| FY 2014 | 2014-12-31 | $4,122,825 | reported |
Cytosorbents Corp · CIK 1175151 · Engraved from SEC EDGAR
